Finland· FI-REL-REL18487

Rimstar

A rifampicin, pyrazinamid, ethambutol und isoniazid product containing rifampicin + isoniazid + pyrazinamide + ethambutol dihydrochloride, registered in Finland by Sandoz A/S. The same ATC class is registered in 4 of our 19 countries.

ATC J04AM06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedRimstarATCJ04AM06REGISTER NO.FI-REL-REL18487PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Rifampicin, pyrazinamid, ethambutol und isoniazid is registered in 4 of 19 countries.

Countries holding a registration under ATC J04AM06 (rifampicin, pyrazinamid, ethambutol und isoniazid), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 3 of them publish a price we can compare per daily dose

Rifampicin, pyrazinamid, ethambutol und isoniazid · ATC J04AM06

4 / 19 countries

  • Denmark
  • Finlandprice
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Rifampicin + Isoniazid + Pyrazinamide + Ethambutol dihydrochloride
Manufacturer
Sandoz A/S
Country
Finland (FI)
ATC code
J04AM06
ATC class
Rifampicin, Pyrazinamid, Ethambutol und Isoniazid
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

8 interactions on record for rifampicin, pyrazinamid, ethambutol und isoniazid.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rifampicin, pyrazinamid, ethambutol und isoniazid · interactions on record

8 records

8 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Rifampicin, pyrazinamid, ethambutol und isoniazid in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rifampicin, pyrazinamid, ethambutol und isoniazid products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Denmark · Rimstar
  • Spain · Rimstar
  • United Kingdom (Northern Ireland) · Rimstar
  • Norway · Rimstar
  • Sweden · Rimstar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3fd5544c-2848-4f9c-807b-c7053215d88f
GET /v1/drugs/3fd5544c-2848-4f9c-807b-c7053215d88f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "tabletti, kalvopäällysteinen",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "rifampisiini, pyratsiiniamidi, etambutoli ja isoniatsidi",
  "ma_number": "17879",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL18487",
  "authorised_at": "2004-03-24"
}

See everything about rifampicin, pyrazinamid, ethambutol und isoniazid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.